Last A$0.35 AUD
Change Today +0.03 / 9.38%
Volume 166.6K
PGC On Other Exchanges
Symbol
Exchange
Frankfurt
As of 1:58 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

paragon care ltd (PGC) Snapshot

Open
A$0.34
Previous Close
A$0.32
Day High
A$0.36
Day Low
A$0.34
52 Week High
10/28/13 - A$0.51
52 Week Low
06/4/14 - A$0.23
Market Cap
22.8M
Average Volume 10 Days
60.5K
EPS TTM
A$0.02
Shares Outstanding
65.2M
EX-Date
10/8/14
P/E TM
20.6x
Dividend
A$0.02
Dividend Yield
6.12%
Current Stock Chart for PARAGON CARE LTD (PGC)

Related News

No related news articles were found.

paragon care ltd (PGC) Related Businessweek News

No Related Businessweek News Found

paragon care ltd (PGC) Details

Paragon Care Limited supplies durable medical equipment and consumable medical products to the health and aged care markets in Australia and New Zealand. Its products include bariatric equipment, beds and mattresses, children and maternity equipment, consulting room equipment, CSSD products, equipment trolleys, food service products, furniture, general ward products, instrument trolleys, ITD equipment carts, IV stand ceiling and wall systems, lighting products, linen and supply products, and materials handling products. The company’s products also comprise medical and medication carts, Medstor materials management systems, mobile computer workstations, mortuary equipment, operating theatre products, patient handling products, patient treatment and surgical stretchers, privacy screen systems, seating and mobility, mobile shower chairs, spectra trolleys, surgical chairs, utility carts, and wire shelving systems. In addition, it provides maintenance services. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. Paragon Care Limited is headquartered in Nunawading, Australia.

paragon care ltd (PGC) Top Compensated Officers

Chief Executive Officer, Managing Director, I...
Total Annual Compensation: A$190.9K
Chief Financial Officer
Total Annual Compensation: A$145.5K
Marketing Manager and Executive Director
Total Annual Compensation: A$144.0K
National Sales Manager
Total Annual Compensation: A$180.0K
Compensation as of Fiscal Year 2014.

paragon care ltd (PGC) Key Developments

Paragon Care Limited Declares Final Dividend for the Year Ended June 30, 2014, Payable on October 31, 2014

Paragon Care Limited has declared a final dividend of 0.75 cents per ordinary share, to be paid on 31 October 2014 in respect of the financial year ended 30 June 2014. The dividend will be paid to all shareholders on the register of members as at the Record Date of 10 October 2014. Combining the final dividend with the interim dividend, the full year dividend will be 1.25 cents per fully paid ordinary share, a 25% increase on the full year dividend of 1 cents per fully paid ordinary share for the 2013 financial year.

Paragon Care Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2014

Paragon Care Limited reported audited consolidated earnings results for the year ended June 30, 2014. For the year, the company reported revenue from continuing operations of AUD 19,416,931 compared to AUD 17,096,447 a year ago. Profit before tax was AUD 1,114,409 compared to AUD 706,173 a year ago. Earnings before interest, tax and depreciation (EBITDA) was AUD 1,784,700 compared to AUD 1,506,834 for the same period a year ago. Earnings before interest and tax (EBIT) were AUD 1,532,727 compared to AUD 1,250,142 for the same period a year ago. Profit after tax was AUD 1,084,891 compared to AUD 739,603 for the same period a year ago. Profit from continuing operations was AUD 1,084,891 compared to AUD 739,603 for the same period a year ago. Profit attributable to owners of the parent was AUD 1,084,891 or 2.0 cents per basic and diluted share compared to profit attributable to owners of the parent of AUD 739,603 or 1.2 cents per basic and diluted share a year ago. Net cash used in operating activities was AUD 2,085,690 compared to net cash provided by operating activities of AUD 725,543 a year ago. Payment for plant and equipment was AUD 191,569 compared to AUD 181,933 a year ago. Payment for development of website was AUD 35,923 compared to AUD 10,785 for the same period a year ago. Payment for purchase of business, net of cash acquired AUD 3,539,767. The increase in revenue was due primarily to encouraging growth in the company's proprietary products particularly Rapini and GM Medical range, along with the recent addition of newly acquired consumable products portfolio.

Paragon Care Limited Announces Resignation of Darryl Levin as Company Secretary and Appointment of Mark Simari as Interim Company Secretary

Paragon Care Limited advised that Mr. Darryl Levin has tendered his resignation as Company Secretary of the company and all of its subsidiaries effective from 13 February 2013. Mr. Mark Simari, Managing Director will assume the role of interim Company Secretary to allow the company to undertake a process of identifying and engaging a replacement for the role.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGC:AU A$0.35 AUD +0.03

PGC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PGC.
View Industry Companies
 

Industry Analysis

PGC

Industry Average

Valuation PGC Industry Range
Price/Earnings 15.5x
Price/Sales 0.6x
Price/Book 1.1x
Price/Cash Flow 18.3x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PARAGON CARE LTD, please visit www.paragoncare.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.